11:25 AM EDT, 07/16/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) shares rose by more than 5% in recent Wednesday trading following the disclosure that Chief Executive John Cox bought 100,000 shares of company stock.

Cox purchased the shares on Monday at a weighted average price of $9.11 per share, according to a filing with the US Securities and Exchange Commission.

Price: 8.77, Change: +0.49, Percent Change: +5.92